18 Apr 2019

MHRA issue a reminder for healthcare professionals administering yellow fever vaccine

This alert highlights two reports of fatal adverse reactions to yellow fever vaccine and the importance of a detailed risk assessment before vaccination MHRA issue a reminder for healthcare professionals administering yellow fever vaccine

The Medicines and Healthcare products Regulatory Agency (MHRA) has published an alert following two fatal adverse reactions to yellow fever vaccine. This publication reinforces the importance of a detailed individual risk assessment before administering yellow fever vaccine especially for those who may be immunocompromised or aged 60 years and older. 

NaTHNaC have been working closely with the MHRA following these two reports of fatal adverse reactions. Measures to minimise risks are being reviewed by an Expert Working Group convened by the Commission on Human Medicines and any updates will be highlighted in due course.

Resources

Polio: Public Health Emergency of International Concern

An update on the polio Public Health Emergency of International Concern (PHEIC) Read more

Global wildfires

A wildfire is an unplanned fire in a natural area such as forest, grassland or prairie Read more

Ebola virus disease (EVD): Democratic Republic of Congo- update

New confirmed cases continue to be reported in North Kivu and Ituri Provinces Read more

Measles outbreaks in the pacific and new entry requirements for travellers

An outbreak of measles is currently affecting a number of islands in the Pacific- travellers should check for possible new entry requirements Read more
Back to Top

VIEW FULL INDEX